Advertisement

Topics

Procognia Group Company Profile

13:06 EST 13th December 2018 | BioPortfolio

Nil

Contact

Email: takabatake@procognia.co.jp


News Articles [668 Associated News Articles listed on BioPortfolio]

Zur Rose Group announces result of rights take-up

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 28.11.2018 / 17:35 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 29.11.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Maricann Group Inc.: Mit Volldampf in die Zukunft! - CEO Ben Ward gibt Ausblick über hervorragende Entwicklung der Wayland Group

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-11-21 / 10:42 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Delek Group Announces Consolidated Second Quarter 2018 Results

TEL AVIV, Israel, Aug. 30, 2018 /PRNewswire/ -- Delek Group Ltd. (TASE: DLEKG) (OTC: DGRLY) (hereinafter: "Delek Group" or "The Group") announced today its results Read more...

#Cannabisstocks: Cronos Group (NASDAQ: $CRON) (TSX: $CRON.TO) Confirms Discussions Regarding Potential Investment by Altria Group (NYSE: $MO)

TORONTO - December 4, 2018 (Investorideas.com Newswire) Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") confirmed that it is engaged in discussions concerning a potentia...

Maricann Group Inc.: Sensations Coup! Einstieg in argentinischen Cannabis Markt - Wayland Group erwirbt über 800 Hektar Anbaufläche!

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-12-11 / 07:20 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Capital increase of Zur Rose Group: Further information on the rights issue

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 03.12.2018 / 06:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Capital increase of the Zur Rose Group: Further information on the rights issue

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 04.12.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

PubMed Articles [1737 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4111 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

The T2T Study of RA Based on SSDM

This study evaluate the Smart System of Disease Management(SSDM)to improve the treat-to-target(T2T) and the safety of drug in the treatment of rheumatoid(RA). All participants will be ...

Companies [1644 Associated Companies listed on BioPortfolio]

Procognia Ltd.

Procognia is helping to develop a fuller understanding of proteins as targets and as therapeutics. Utilising technologies based around proteins arrays, we provide both the means for unraveling disease...

Procognia Group

Nil

Procognia Inc.

Procognia is helping to develop a fuller understanding of proteins as targets and as therapeutics. Utilising technologies based around proteins arrays, we provide both the means for unraveling disease...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

Sense Proteomic Limited

Sense Proteomic Limited is a biomarker discovery company utilising its proprietary protein array technology to discover and commercialise autoantibody biomarkers for cancer and autoimmune diseases. We...

More Information about "Procognia Group" on BioPortfolio

We have published hundreds of Procognia Group news stories on BioPortfolio along with dozens of Procognia Group Clinical Trials and PubMed Articles about Procognia Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Procognia Group Companies in our database. You can also find out about relevant Procognia Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record